Financial News
Latest News about BIIB
Recent news which mentions BIIB
3 Things About Cassava Sciences That Smart Investors Know
August 05, 2021
From Motley Fool
Tickers
BIIB
From Motley Fool
Biogen: Does Aduhelm Make it the Next Dendreon?
July 30, 2021
From InvestorPlace
From Benzinga
Why Biogen's Stock Has Likely Peaked
July 30, 2021
From Motley Fool
From Motley Fool
From Benzinga
From Motley Fool
From Motley Fool
From Motley Fool
3 Diverse Forever Tech Stocks to Buy Today
July 28, 2021
From InvestorPlace
From Benzinga
Analysis Shows Biogen-Eisai's Aduhelm Slows Cognitive, Functional Decline In Early Alzheimer's Patients
July 27, 2021
From Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
From Benzinga
Could These 3 Potential Blockbusters Transform Biogen?
July 25, 2021
From Motley Fool
Cassava Sciences Stock Soars In Anticipation Of Alzheimer's Data: A Technical Analysis
July 22, 2021
From Benzinga
Biogen, under pressure, tells investors it ‘stands by’ the FDA review process for its Alzheimer’s drug
July 22, 2021
From MarketWatch
From InvestorPlace
From Benzinga
An ‘above-average growth story’ is about to unfold. 3 stocks to play it from a top-performing fund manager.
July 22, 2021
From MarketWatch
From Motley Fool
From Motley Fool
Earnings Scheduled For July 22, 2021
July 22, 2021
From Benzinga
Here's Why Cassava Sciences Is Surging Today
July 21, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.